share_log

Wedbush Reiterates Outperform on Imax, Maintains $22 Price Target

Benzinga ·  Feb 23 21:49

Wedbush analyst Alicia Reese reiterates Imax (NYSE:IMAX) with a Outperform and maintains $22 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment